Doximity bought Pathway Medical for $63 million to bring smart AI tools right into the Doximity app that most U.S. doctors already use. Now, over 80% of American physicians will get free access to up-to-date medical guidelines, drug info, and important studies, making their daily work easier and faster. Pathway’s AI is very accurate and only uses trusted medical sources. This big move shows how AI help is quickly becoming a normal part of doctors’ everyday apps. Investors liked the news, and Doximity plans to add more AI features soon.
What does Doximity’s acquisition of Pathway Medical mean for clinicians?
Doximity’s $63 million acquisition of Pathway Medical integrates advanced, evidence-based AI tools directly into the Doximity app, giving over 80% of U.S. physicians free access to accurate clinical guidelines, drug data, and landmark studies, streamlining point-of-care decision-making and workflow.
Doximity Pays $63 Million to Put an AI Doctor in Every Pocket
- Deal closed July 29, 2025
Doximity, the platform already used by more than 80 % of U.S. physicians, has closed the acquisition of Montreal-based Pathway Medical for a total consideration of $63 million* ($26 million cash + up to $37 million in equity). Every one of Pathway’s six employees – including three physicians – is joining the larger Doximity team.
What Pathway brings to the table
| Asset | Scale | Clinical Relevance |
|---|---|---|
| Structured medical dataset | 7 years in the making, physician-curated | Covers guidelines, drugs, landmark trials for every major specialty |
| AI accuracy | 96 % on USMLE benchmark | Outperforms other public models |
| Reach | 1 million registered users across 10 000 facilities | Used at point of care today |
Pathway’s editorial policy is strict: every entry must be manually graded for evidence quality and sourced only from peer-reviewed English-language journals or recognized medical organizations.
Integration plan – first look
- Immediate : Pathway’s search engine will be embedded free of charge inside the existing Doximity app, letting clinicians query evidence-based answers without leaving the workflow.
- Late 2025: AI scribe, prior-auth drafting and literature-search upgrades based on the combined dataset.
- 2026 : Expansion into additional specialties and deeper EHR-level integration.
CEO Jeff Tangney said Doximity went after “the best company at answering physicians’ questions using AI,” while Pathway CEO Jon Hershon noted the deal will “accelerate our roadmap and bring our AI and medical knowledge graph to millions for free.”
Market reaction
Investors liked the move:
- DOCS stock jumped 11–14 % in the first trading session after the announcement (August 8, 2025).
- Analysts maintained a “Moderate Buy” rating; Wells Fargo raised its price target to $62 .
Broader industry signal
The transaction is part of a wider wave of AI adoption in clinical knowledge management. Similar initiatives include Canada Health Infoway’s AI Scribe Program, launched this year to reduce documentation burden. Doximity’s large installed base gives the combined platform immediate scale that most competitors lack.
For clinicians, the message is clear: powerful, evidence-graded AI assistance is moving from optional subscription tool to default feature inside the apps they already open every day.
FAQ: Doximity Acquires Pathway Medical
What is the total value of the transaction?
The deal is valued at $63 million, consisting of $26 million in cash and up to $37 million in additional equity grants tied to performance milestones.
How does Pathway’s AI compare with other clinical-assistance tools?
Pathway’s model scores a record 96 % on the U.S. Medical Licensing Examination benchmark, surpassing most existing tools and providing highly accurate, evidence-based answers at the point of care.
What dataset is being added to Doximity?
Doximity is gaining access to one of the largest structured medical datasets ever compiled, covering guidelines, landmark trials, and drug data across all major specialties and sourced exclusively from English-language, peer-reviewed journals.
How many users and facilities does this new dataset reach?
Pathway already serves more than 1 million registered users across 10,000 healthcare facilities worldwide, and all of these users will eventually have free access to the integrated platform.
When was the acquisition officially completed?
The transaction closed on 29 July 2025 and is already reflected in Doximity’s Q1 earnings, which beat Wall Street estimates and led to an 11 %–14 % single-day surge in DOCS stock.
